Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen

Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen

Aim. To implement in 2009—2012 the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen in patients with type 1 diabetes mellitus (DM) to evaluate the efficiency and safety of therapy with human insulin analogues...

Full description

Bibliographic Details
Main Authors: N V Efremova, L L Bolotskaya, D S Atarshchikov, O N Bondarenko, A V Ilyin, M V Shestakova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2015-10-01
Series:Терапевтический архив
Subjects:
type 1 diabetes mellitus
human insulin analogues
glargine (lantus)
glulisine (apidra)
glycemic control
hypoglycemia
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31822

Similar Items

Similar Items